Home » Merck Takes Loss on Drug, Issues Low Forecast
Merck Takes Loss on Drug, Issues Low Forecast
Merck & Co., the second largest U.S. drugmaker, forecast 2011 earnings that missed analyst estimates and posted a fourth-quarter loss after taking a $1.7 billion charge to write down its experimental blood thinner.
NJ
NJ
Upcoming Events
-
07May
-
14May
-
30May